000 | 01772 a2200553 4500 | ||
---|---|---|---|
005 | 20250516004146.0 | ||
264 | 0 | _c20101025 | |
008 | 201010s 0 0 eng d | ||
022 | _a1555-7162 | ||
024 | 7 |
_a10.1016/j.amjmed.2010.05.021 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhou, Xiao | |
245 | 0 | 0 |
_aIncidence and risk factors of venous thromboembolic events in lymphoma. _h[electronic resource] |
260 |
_bThe American journal of medicine _cOct 2010 |
||
300 |
_a935-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aCreatinine _xblood |
650 | 0 | 4 |
_aDoxorubicin _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemoglobins _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 |
_aLymphoma _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethotrexate _xadverse effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPulmonary Embolism _xepidemiology |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSex Factors |
650 | 0 | 4 |
_aVenous Thromboembolism _xepidemiology |
650 | 0 | 4 |
_aVenous Thrombosis _xepidemiology |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aTeegala, Shyam | |
700 | 1 | _aHuen, Auris | |
700 | 1 | _aJi, Yuan | |
700 | 1 | _aFayad, Luis | |
700 | 1 | _aHagemeister, Fredrick B | |
700 | 1 | _aGladish, Gregory | |
700 | 1 | _aVadhan-Raj, Saroj | |
773 | 0 |
_tThe American journal of medicine _gvol. 123 _gno. 10 _gp. 935-41 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjmed.2010.05.021 _zAvailable from publisher's website |
999 |
_c20226750 _d20226750 |